OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma

HTML

Year: 2016
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2015.63.4121
Authors: Sofie Wilgenhof, Jurgen Corthals, Carlo Heirman, Nicolas van Baren, Sophie Lucas, Pia Kvistborg, Kris Thielemans, Bart Neyns
Institutions: Vrije Universiteit Brussel, Ludwig Cancer Research, The Netherlands Cancer Institute, de Duve Institute, Universitair Ziekenhuis Brussel, UCLouvain
Language: English

Topic: Immunotherapy and Immune Responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: advanced melanoma, autologous dendritic cells, mRNA electroporation, ipilimumab, CTLA-4 blockade, combination immunotherapy, disease control rate, immune-related adverse events
SDG: Good health and well-being

Open Access status: closed

Funder: American Society of Clinical Oncology
OpenAlex ID: W2291366206
FWCI: 14.05
Cites: 45
Cited by: 332
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms